Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum: Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions

American Journal of Pathology

Volumn 154, Issue 6, 1999, Pages 1793-1804

  Verhagen, Claudia ^a   Faber, William ^a   Klatser, Paul ^b   Buffing, Anita ^a   Naafs, Ben ^c   Das, Pranab ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM ANTIGEN; PHENOLIC GLYCOLIPID I;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LEPROSY; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032983677     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65435-1     Document Type: Article

References (52)

1. Ridley DS, Jopling WH: Classification of leprosy according to immunity: a five-group system. Int J Lepr 1966, 34:255-273
2. Das PK, Grange JM: Mycobacteria in relation to tissue immune response and pathogenesis. Rev Med Microbiol 1993, 4:15-23
3. Ridley DS: Reactions in leprosy. Lepr Rev 1969, 40:77-81
4. Barnetson RSC, Bjune G, Pearson JMH, Kronvall G: Cell mediated and humoral immunity in 'reversal reactions'. Int J Lepr 1976, 44:267-274
5. Lienhardt C, Fine PEM: Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr Rev 1994, 65:9-33
6. Wemambu SNC, Turk JL, Waters MFR, Rees RJW: Erythema nodosum leprosum: A clinical manifestation of the Arthus phenomenon. Lancet 1969, ii:933-935
7. Modlin RL, Gebhard JF, Taylor CR, Rea TH: In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol 1983, 53:17-24
8. Shields MJ: The importance of immunologically effective contact with environmental mycobacteria. The Biology of the Mycobacteria. Edited by Ratledge C, Stanford J, London, Academic Press, 1983, pp 343-415
9. Grange JM: Environmental mycobacteria and human disease. Lepr Rev 1991, 62:353-361
10. Thole JER, Wieles B, Clark-Curtiss JE, Ottenhoff THM, Rinke de Witt TF: Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview. Mol Microbiol 1995, 18:791-800
11. Sengupta U : Mycobacterium leprae antigens and their utility in immunodiagnostics of leprosy. Trop Med Parasitol 1990, 41:361-362
12. Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ: Serological monitoring of the response to chemotherapy in leprosy patients. Int J Lepr 1993, 61:35-43
13. Roche PW, Theuvenet WJ, Britton WJ: Risk factors for type-1 reactions in borderline leprosy patients. Lancet 1991, 338:654-657
14. Levis WR, Meeker HC, Schuller-Levis G, Sersen E, Schwerer B: IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence. J Invest Dermatol 1986, 86:529-534
15. Rumschlag HS, Shinnick TM, Cohen ML: Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-and 32-kilodalton antigens of Mycobacterium tuberculosis. J Clin Microbiol 1988, 26:2200-2202
16. Das PK, Rambukkana A, Baas JG, Groothuis DG, Halperin M: Enzyme-linked immunosorbent assay for distinguishing serological responses of lepromatous and tuberculoid leprosies to the 29/33-kilodalton doublet and 64-kilodalton antigens of Mycobacterium tuberculosis. J Clin Microbiol 1990, 28:379-382
17. Launois P, N'Diaye Niang M, Drowart A, van Vooren JP, Sarthou JL, Lalu T, Millan J, Huygen K: IgG response to purified 65-and 70-kDa mycobacterial heat shock proteins and to antigen 85 in leprosy. Int J Lepr 1994, 62:48-54
18. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL: CD 1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230
19. Mehra V, Brennan PJ, Rada E, Convit J, Bloom BR: Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 1984, 308:194-196
20. Koster FT, Scollard DM, Umland ET, Fishbein DB, Hanly WC, Brennan PJ, Nelson KE: Cellular and humoral immune response to phenolic glycolipid antigen (PhenGL-I) in patients with leprosy. J Clin Microbiol 1987, 25:551-556
21. Lee SP, Stoker NG, Grant KA, Handzel ZT, Hussain R, McAdam KPWJ, Dockrell HM: Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun 1989, 57:2475-2480
22. Gulle H, Schoel B, Chiplunkar S, Gangal S, Deo MG, Kaufmann SHE: T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Int J Lepr 1992, 60:44-53
23. Launois P, N'Diaye Niang MB, Sarthou JL, Rivier F, Drowart A, Van Vooren JP, Millan J, Huygen K: T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen. Scand J Immunol 1993, 38:167-176
24. Janson AAM, Klatser PR, van der Zee R, Cornelisse YE, de Vries RRP, Thole JER, Ottenhoff THM: A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. J Immunol 1991, 147:3530-3537
25. Thole JER, Janson AAM, Kifle A, Howe RC, McLean K, Nurilygn A, Filley E, Shannon EJ, Bulla GJ, Hermans J, De Vries RRP, Frommel D, Rinke De Wit TF: Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T cell responses to antigens in M. leprae nonresponders. Int J Lepr 1995, 63:369-380
26. Klatser PR, Janson AAM, Thole JER, Buhrer S, Bos C, Soebono H, De Vries RRP: Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-type leprosy patients and healthy controls. Int J Lepr 1997, 65:178-189
27. Khanolkar SR, Mackenzie CD, Lucas SB, Hussen A, Girdhar BK, Katoch K, McAdam KPWJ: Identification of Mycobacterium leprae antigens in tissues of leprosy patients using monoclonal antibodies. Int J Lepr 1989, 57:652-658
28. Narayanan RB, Ramu G, Sinha S, Sengupta U, Malaviya GN, Desikan KV: Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies. Int J Lepr 1985, 57: 258-264
29. Narayanan RB, Girdhar BK, Malaviya GN, Sengupta U: In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies. Immunology Lett 1990, 24:179-184
30. Wang T, Izumi S, Butt KI, Kawatsu K, Maeda Y: Demonstration of PGL-I and LAM-B antigens in paraffin sections ot leprosy skin lesions. Jpn J Leprosy 1992, 61:165-174
31. Rambukkana A, Das PK, Burggraaf JD, Young S, Faber WR, Thole JER, Harboe M: Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun 1992, 60: 5172-5181
32. Ridley DS: Skin Biopsy in Leprosy, ed 2. Basel, Ciba-Giegy, 1985
33. Klatser PR, de Wit MYL, Kolk AHJ, Hartskeerl RA: Characterization of murine B-cell epitopes on the Mycobacterium leprae proline-rich antigen by use of synthetic peptides. Infect Immun 1991, 59:433-436
34. Buchanan TM, Nomaguchi H, Anderson DC, Young RA, Gillis TP, Britton WJ, Ivanyi J, Kolk AHJ, Closs O, Bloom BR, Mehra V: Characterisation of antibody-reactive epitopes on 65-kilodalton protein of Mycobacterium leprae. Infect Immun 1987, 55:1000-1003
35. Kolk AHJ, Ly Ho M, Klatser PR, Eggelte TA, Kuijper S, de Jonge S, van Leeuwen J: Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae. Clin Exp Immunol 1984, 58:511-521
36. Fujiwara T, Minagawa F, Sakamoto Y, Douglas JT: Epitope mapping of twelve monoclonal antibodies against the phenolic glycolipid-I of M. leprae. Int J Lepr 1997, 65:477-86
37. Hsu SM, Raine L, Fanger H: Use of avidin biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
38. Van der Loos CM, Becker AE, van den Oord JJ: Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J 1993, 25:1-13
39. Van der Vliet GME, Cho S-N, Kampirapap K, Van Leeuwen J, Schukkink AF, Van Gemen B, Das PK, Faber WR, Walsh GP, Klatser PR: Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients. Int J Lepr 1996, 64:396-403
40. Brett SJ, Payne SN, Gigg J, Burgess P, Gigg R: Use of synthetic glycoconjugates containing the Mycobacterium leprae specific immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Clin Exp Immunol 1986, 64:476-83
41. Mshana RN, Belehu A, Stoner GL, Harboe M, Haregewoin A: Demonstration of mycobacterial antigens in leprosy tissues. Int J Lepr 1982, 50:1-10
42. Rambukkana A, Das PK, Witkamp L, Young S, Meinardi MMHM, Bos JD: Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 1993, 100:87-92
43. Van den Akker TW, Naafs B, Kolk AHJ, De Glopper-van der Veer E, Chin RA, Lien A, Van Joost T: Similarity between mycobacterial and human epidermal antigens. Br J Dermatol 1992, 127:352-358
44. Naafs B, Kolk AHJ, Chin A, Lien RAM, Faber WR, Van Dijk G, Kuijper S, Stolz E, Van Joost T: Anti-Mycobacterium leprae monoclonal antibodies crossreact with human skin: an alternative explanation for the immune responses in leprosy. J Invest Dermatol 1990, 94:685-688
45. Mshana RN, Humber DP, Harboe M, Belehu A: Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique. Clin Immunol Immunopathol 1983, 29:359-368
46. Shetty VP, Uplekar MW, Antia NH: Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy. Acta Neuropathol 1994, 88:300-306
47. Barras U, Ladiwala U, Birdi TJ, Antia NH: Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients. Br J Exp Pathol 1987, 68:733-741
48. Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL: Tumor necrosis factor production in patients with leprosy. Infect Immun 1992, 60:1441-146
49. Sarno EN, Grau GE, Vieira LMM, Nery JA: Serum levels of tumor necrosis factor alpha and interleukin 1β during leprosy reactional states. Clin Exp Immunol 1991, 84:103-108
50. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA: CD1c restricts responses of mycobacteria-specific T cells: evidence for antigen presentation by a second member of the human CD1 family. J Immunol 1996, 157:2975-2803
51. Lai A, Fat RFM, Char Pin Lin M, Van Fewth R, Harboe M: In vitro synthesis of antimycobacterial antibodies in biopsies from skin lesions of leprosy patients. Infect Immun 1980, 27:227-230
52. Bos JD: Skin immune system (SIS). Cutaneous Immunology and Clinical Immunodermatology. Edited by Bos JD. New York, CRC Press, 1997